Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $306.2200 (0.45%) ($303.7000 - $308.5700) on Thu. May. 29, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.57% (three month average) | RSI | 67 | Latest Price | $306.2200(0.45%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1% a day on average for past five trading days. | Weekly Trend | REGN advances 3.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XBI(38%) XLV(38%) QQQ(31%) SPY(30%) XLK(28%) | Factors Impacting REGN price | REGN will decline at least -1.285% in a week (0% probabilities). VIXM(-13%) TLT(-6%) SHY(-3%) IGOV(-3%) UUP(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.285% (StdDev 2.57%) | Hourly BBV | 0 () | Intraday Trend | 0.3% | | | |
|
5 Day Moving Average | $303.01(1.06%) | 10 Day Moving Average | $298.89(2.45%) | 20 Day Moving Average | $294.16(4.1%) | To recent high | -8.1% | To recent low | 9.6% | Market Cap | $32.468b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |